Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV
Mary Morrow, Samantha MaWhinney, Ryan P. Coyle, et al.
The Journal of Infectious Diseases (2019) Vol. 220, Iss. 4, pp. 635-642
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The microbiome and gynaecological cancer development, prevention and therapy
Paweł Łaniewski, Zehra Esra Ilhan, Melissa M. Herbst‐Kralovetz
Nature Reviews Urology (2020) Vol. 17, Iss. 4, pp. 232-250
Open Access | Times Cited: 297
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions
Matthew A. Spinelli, Jessica E. Haberer, Peter R. Chai, et al.
Current HIV/AIDS Reports (2020) Vol. 17, Iss. 4, pp. 301-314
Open Access | Times Cited: 117
Viral and host mediators of non-suppressible HIV-1 viremia
Abbas Mohammadi, Behzad Etemad, Xin Zhang, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3212-3223
Open Access | Times Cited: 20
Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication
Jean‐Jacques Parienti, Anna Fournier, L. Cotte, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 33
Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention
Paul K. Drain, Ashley R. Bardon, Jane M. Simoni, et al.
Current HIV/AIDS Reports (2020) Vol. 17, Iss. 5, pp. 487-498
Open Access | Times Cited: 32
Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa
Lauren Jennings, Reuben N. Robbins, Nadia Nguyen, et al.
AIDS (2022) Vol. 36, Iss. 7, pp. 933-940
Open Access | Times Cited: 18
Urine tenofovir adherence testing: Perspectives of recently diagnosed South African adolescents and young adults with HIV accessing care via mobile HIV clinics
Michalina A. Montaño, Siyaxolisa Sindelo, Amanda Fata, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0318308-e0318308
Open Access
Intracellular dried blood spot metabolite concentrations for assessing antiretroviral adherence and HIV progression
Julie B. Dumond
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2025)
Closed Access
Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV
José Castillo‐Mancilla, Mary Morrow, Ryan P. Coyle, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 9
Open Access | Times Cited: 21
Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons With Human Immunodeficiency Virus Receiving Tenofovir Alafenamide and Emtricitabine–Based Antiretroviral Therapy (QUANTI-TAF)
Ryan P. Coyle, Mary Morrow, Sarah Mann, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 5, pp. 1233-1241
Closed Access | Times Cited: 3
The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study
Sarah Mann, Weiqun Tong, Alison G. Abraham, et al.
AIDS (2024) Vol. 38, Iss. 14, pp. 1922-1931
Closed Access | Times Cited: 3
Moderately High Tenofovir Diphosphate in Dried Blood Spots Indicates Drug Resistance in Viremic Persons Living with HIV
Jenna Yager, Ryan P. Coyle, Stacey S. Coleman, et al.
Journal of the International Association of Providers of AIDS Care (JIAPAC) (2019) Vol. 18
Open Access | Times Cited: 20
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV
Ryan P. Coyle, Mary Morrow, Stacey S. Coleman, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 75, Iss. 6, pp. 1591-1598
Open Access | Times Cited: 20
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens
Gert U. van Zyl, Lauren Jennings, Tracy Kellermann, et al.
AIDS (2022) Vol. 36, Iss. 14, pp. 2057-2062
Open Access | Times Cited: 12
Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir–Lamivudine–Dolutegravir as First-Line or Second-Line Antiretroviral Therapy
Jennifer K. van Heerden, Graeme Meintjes, David Barr, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2024) Vol. 95, Iss. 3, pp. 260-267
Open Access | Times Cited: 2
Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots: Results from a Pilot Study Among Patients and Providers in Cape Town, South Africa
Christopher M. Ferraris, Paul A. D’Avanzo, Lauren Jennings, et al.
AIDS and Behavior (2023) Vol. 27, Iss. 10, pp. 3478-3486
Closed Access | Times Cited: 6
Long-Acting Treatments for Hepatitis B
David L. Thomas, Jennifer J. Kiser, Marc M. Baum
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_4, pp. S517-S524
Open Access | Times Cited: 10
HIV, aging, and adherence: an update and future directions
Sarah Mann, José Castillo‐Mancilla
Current Opinion in HIV and AIDS (2020) Vol. 15, Iss. 2, pp. 134-141
Closed Access | Times Cited: 12
Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring
Xin Niu, Rachel W. Kubiak, Oraphan Siriprakaisil, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 8
Open Access | Times Cited: 8
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
Tim R. Cressey, Oraphan Siriprakaisil, Rachel W. Kubiak, et al.
International Journal of Infectious Diseases (2020) Vol. 97, pp. 365-370
Open Access | Times Cited: 11
Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients With HIV on Antiretroviral Treatment
Grant Ellsworth, Leah Burke, Martin T. Wells, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2020) Vol. 86, Iss. 1, pp. 73-80
Open Access | Times Cited: 11
Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence
Mary Morrow, Samantha MaWhinney, Ryan P. Coyle, et al.
AIDS (2021) Vol. 35, Iss. 12, pp. 1949-1956
Open Access | Times Cited: 10
The Contributions of Clinical Pharmacology to HIV Cure Research
Courtney V. Fletcher, Shetty Ravi Dyavar, Arpan Acharya, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 2, pp. 334-345
Open Access | Times Cited: 8
Beyond HIV viral load: application of pharmacologic measures to identify ART adherence mismatch
Michael Kristofich, Peter L. Anderson, José Castillo‐Mancilla
Therapeutic Advances in Infectious Disease (2021) Vol. 8, pp. 204993612110105-204993612110105
Open Access | Times Cited: 8
REverSe TRanscrIptase chain termination (RESTRICT) for selective measurement of nucleotide analogs used in HIV care and prevention
Ayokunle O. Olanrewaju, Benjamin P. Sullivan, Alicia Gim, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top